FGFR4 Arg388 Allele Is Associated With Resistance to Adjuvant Therapy in Primary Breast Cancer
- 10 August 2006
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (23), 3747-3755
- https://doi.org/10.1200/jco.2005.04.8587
Abstract
Purpose A recent study presented first evidence that a single nucleotide polymorphism (SNP) at codon 388 of fibroblast growth factor receptor 4 (FGFR4) gene, causing a transmembrane domain missense...Keywords
This publication has 31 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Fgfr2 is required for limb outgrowth and lung-branching morphogenesisProceedings of the National Academy of Sciences, 1999
- Fibroblast growth factor receptors: lessons from the genesTrends in Biochemical Sciences, 1998
- Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasNature Genetics, 1997
- Lessons from Hereditary Colorectal CancerCell, 1996
- Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricansNature Genetics, 1995
- Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasiaNature, 1994
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987